LYELL IMMUNOPHARMA INC COM NEW

LYELL IMMUNOPHARMA INC COM NEW is a security (CUSIP 55083R203) tracked across SEC portfolio filings. 79 institutional managers reported $289.2M on Form 13F as of 2026-06-30; 5 registered fund positions totaling $3.8M via N-PORT as of 2026-04-30.

Summary

Top institutional holders (Form 13F)

Showing 15 of 79 managers by value.

ManagerLocationValueShares
ARCH Venture Management, LLCCHICAGO, IL$65.1M3,247,162
MWG Caph LtdWASHINGTON, DC$31.0M1,008,116
GSK plcLondon, X0$30.3M1,512,659
VANGUARD GROUP INCValley Forge, PA$25.4M826,430
MWG Management Ltd.Washington, DC$16.4M1,008,116
Foresite Capital Management IV, LLCLarkspur, CA$16.1M800,399
Almitas Capital LLCSANTA MONICA, CA$11.6M577,807
Orland Properties LtdWashington, DC$10.6M754,698
Foresite Capital Management V, LLCLarkspur, CA$9.6M477,078
MILLENNIUM MANAGEMENT LLCNEW YORK, NY$9.2M458,905
CITADEL ADVISORS LLCMIAMI, FL$7.9M381,462
venBio Partners LLCSAN FRANCISCO, CA$6.8M337,697
SUSQUEHANNA INTERNATIONAL GROUP, LLPBALA CYNWYD, PA$6.2M310,198
Alphabet Inc.Mountain View, CA$5.9M293,256
BlackRock, Inc.New York, NY$3.8M191,820

Top fund holders (N-PORT)

FundRegistrantValue% of fund
VANGUARD EXTENDED MARKET INDEX FUNDVANGUARD INDEX FUNDS$3.3M0.40%
U.S. MICRO CAP PORTFOLIODFA INVESTMENT DIMENSIONS GROUP INC$198K0.26%
VANGUARD BALANCED INDEX FUNDVANGUARD VALLEY FORGE FUNDS$187K0.03%
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUNDVANGUARD INSTITUTIONAL INDEX FUNDS$185K0.06%
Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Funds$3K0.01%

More